- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04934033
Cohort of Healthy People in Brain MRI, Together With a Language and Cognitive Assessment at the University Hospital of Nice (NHB)
July 1, 2022 updated by: Centre Hospitalier Universitaire de Nice
Nice Healthy Brain - Cohort of Healthy People in Brain MRI, Together With a Language and Cognitive Assessment at the University Hospital of Nice
The aim of this study is to constitute a cohort of healthy subjects in brain MRI, including functional and diffusion sequences, together with a language and cognitive assessment.
This will make it possible to compare the data with those obtained in the same center and under the same examination conditions in brain tumor patients.
The investigators seek to evidence general patterns of cerebral morphological and functional changes, correlated with behavioural scores, in brain-damaged patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Provence Alpes Cote d'Azur
-
Nice, Provence Alpes Cote d'Azur, France, 06001
- University Hospital of Nice
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
26 years to 71 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- cerebral and psychiatric healthy volunteer
- agreeing to participate in this research
- 30 and 50 years old or between 60 and 75 years old
Exclusion Criteria:
- contra-indication to MRI
- refusal of patient participation
- pregnant, lactating or parturient women
- vulnerable people
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Healthy volunteers
The participants will constitue a cohort of healthy volunteers, they will have a MRI, and language and cognitive assessment.
|
The participants will have a MRI, and language and cognitive assessments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of cerebral MRI
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 23, 2021
Primary Completion (Actual)
June 20, 2022
Study Completion (Actual)
June 20, 2022
Study Registration Dates
First Submitted
June 9, 2021
First Submitted That Met QC Criteria
June 14, 2021
First Posted (Actual)
June 22, 2021
Study Record Updates
Last Update Posted (Actual)
July 5, 2022
Last Update Submitted That Met QC Criteria
July 1, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 21-AOI-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
Yuhan CorporationNot yet recruiting
-
Central Hospital, Nancy, FranceNot yet recruitingHealthy SubjectsFrance
-
Lutroo Imaging LLCStanford UniversityRecruiting
Clinical Trials on Neurological assessments
-
Institut National de la Santé Et de la Recherche...University College, LondonCompletedHuntington Disease | White Matter AlterationsFrance
-
BRAINBox Solutions IncRecruitingMild Traumatic Brain InjuryUnited States
-
University of PennsylvaniaRecruiting
-
Association de Recherche Bibliographique pour les...University of Cambridge; Centre Hospitalier Princesse Grace; Institut National...CompletedBrain Injuries | Sport Injury | Concussion, BrainMonaco
-
West China HospitalRigshospitalet, Denmark; St Thomas' Hospital, LondonNot yet recruitingBrain Diseases | Aortic Valve Stenosis
-
University of PennsylvaniaRecruitingTauopathiesUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingConsciousness DisorderFrance
-
University of PennsylvaniaRecruitingTauopathiesUnited States
-
Hospices Civils de LyonRecruitingSocial Perception in Parkinson's DiseaseFrance
-
University Hospital, BordeauxTerminatedAmyotrophic Lateral Sclerosis | ALSFrance